サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1576500

デジタルバイオマニュファクチャリングの市場規模、シェア、予測、動向分析：提供内容別（ソフトウェア・ハードウェア）、機能別（製品設計・分析、自動化）、用途別（MAB、タンパク質、ワクチン）、バイオプロセス別 - 2031年までの世界予測

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2031

出版日
ページ情報
英文
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
デジタルバイオマニュファクチャリングの市場規模、シェア、予測、動向分析：提供内容別（ソフトウェア・ハードウェア）、機能別（製品設計・分析、自動化）、用途別（MAB、タンパク質、ワクチン）、バイオプロセス別 - 2031年までの世界予測
出版日: 2024年09月01日
発行: Meticulous Research
ページ情報: 英文
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルバイオマニュファクチャリング市場は、2024年から2031年までのCAGR13.3%で、2031年までに508億9,000万米ドルに達すると予測されます。

広範な二次調査と一次調査、市場シナリオの詳細な分析を経て、当レポートは主要産業の促進要因・抑制要因・課題・機会の分析から構成されています。デジタルバイオマニュファクチャリング市場の成長は、生物製剤の需要拡大、主要企業によるバイオ医薬品工場の能力増強、プロセス最適化のニーズの高まり、品質基準と規制遵守への注目の高まり、バイオ医薬品の強力な研究開発パイプライン、連続バイオプロセスへの注目の高まりが原動力となっています。しかし、技術導入のコストが高いこと、バイオ医薬品の開発・製造プロセスが複雑であることが、この市場の成長を抑制しています。

さらに、インダストリー4.0技術の導入、高度なデータ分析ツールの利用可能性、バイオプロセス4.0へのシフトは、市場成長の機会を生み出すと期待されています。しかし、下流工程のプロセス分析技術（PAT）導入における複雑さと、バイオ医薬品製造に必要な集中的な資本要件は、デジタルバイオマニュファクチャリング市場における主要課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

  • 概要
  • 促進要因
    • 生物製剤の需要拡大
    • 主要企業によるバイオ医薬品工場の能力増強
    • プロセス最適化のニーズの高まり
    • 品質基準と規制遵守への関心の高まり
    • バイオ医薬品の強力な研究開発パイプライン
    • 連続バイオプロセスへの注目の高まり
  • 抑制要因
    • 技術導入の高コスト
    • バイオ医薬品の複雑な開発・製造プロセス
  • 機会
    • インダストリー4.0のイントロダクション
    • 高度なデータ分析ツールの利用可能性
    • バイオプロセス4.0へのシフト
  • 課題
    • 下流工程へのプロセス分析技術（PAT）導入における複雑さ
    • バイオ医薬品製造のための集中的な資本要件
  • 要因分析
  • 動向
    • デジタルツインテクノロジー
    • 人工知能（AI）と機械学習（ML）の統合
  • 規制分析
  • 価格分析
  • ポーターのファイブフォース分析

第5章 デジタルバイオマニュファクチャリング市場の評価：提供内容別

  • 概要
  • ソフトウェア
    • タイプ別
      • プロセス分析技術
      • データ分析ソフトウェア
      • 製造実行システム
      • デジタルツイン
    • 展開方式別
      • クラウドベース
      • オンプレミス
  • ハードウェア

第6章 デジタルバイオマニュファクチャリング市場の評価：機能別

  • 概要
  • 製品設計
  • プロセス最適化・分析
  • 自動化・制御
  • その他の機能

第7章 デジタルバイオマニュファクチャリング市場の評価：バイオプロセス別

  • 概要
  • 上流工程バイオプロセス
  • 下流工程バイオプロセス

第8章 デジタルバイオマニュファクチャリング市場の評価：用途別

  • 概要
  • モノクローナル抗体 (MAB)
  • 組換えホルモン/タンパク質
  • ワクチン
  • 細胞ベース生物製剤
  • 遺伝子ベース生物製剤

第9章 デジタルバイオマニュファクチャリング市場の評価：エンドユーザー別

  • 概要
  • バイオ医薬品企業
  • 学術・研究機関
  • CDMO・CRO

第10章 デジタルバイオマニュファクチャリング市場の評価：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • スイス
    • デンマーク
    • アイルランド
    • ベルギー
    • その他欧州（RoE）
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋（RoAPAC）
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ（RoLATAM）
  • 中東・アフリカ

第11章 競合分析

  • 概要
  • 主要成長戦略
  • 競合ベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 先行企業
    • 新興企業
  • 市場シェア分析/市場ランキング、主要企業別（2023年）

第12章 企業プロファイル（企業概要、財務概要、製品ポートフォリオ、戦略展開状況、SWOT分析）

  • GE Healthcare Technologies, Inc.
  • Siemens Xcelerator（subsidiary of Siemens）
  • Cytiva（subsidiary of Danaher Corporation）
  • ABB Ltd.（Sweden）
  • Sanofi S.A.
  • Emerson Electric Co.
  • Honeywell International, Inc.
  • SAP SE
  • OVO Biomanufacturing Ltd.
  • Schneider Electric SE
  • Dassault Systemes
  • Oracle Corporation
  • 3M

（注：上位5社のSWOT分析を掲載）

第13章 付録

図表

LIST OF TABLES

  • Table 1 Global Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 2 Global Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 3 Global Digital Biomanufacturing software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Process Analytical Technology Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Data Analysis Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global Manufacturing execution System Market, by Country/Region, 2022-2031 (USD Million)
  • Table 7 Global Digital Twin Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global Digital Biomanufacturing Software Market, by Deployment, 2022-2031 (USD Million)
  • Table 9 Global Cloud-based Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global On-Premises Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Digital Biomanufacturing Hardware Market, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 13 Global Digital Biomanufacturing Market for Product Design Functionality, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Digital Biomanufacturing Market for Process Optimization & Analytics, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Digital Biomanufacturing Market for Automation & Control, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global Digital Biomanufacturing Market for Other Functionalities, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 18 Global Digital Biomanufacturing Market for Upstream Bioprocessing, by Country/ Region, 2022-2031 (USD Million)
  • Table 19 Global Digital Biomanufacturing Market for Downstream Bioprocessing, by Country/ Region, 2022-2031 (USD Million)
  • Table 20 Global Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 21 Global Digital Biomanufacturing Market for Monoclonal Antibodies, by Country/ Region, 2022-2031 (USD Million)
  • Table 22 Global Digital Biomanufacturing Market for Recombinant Hormones/Proteins, by Country/ Region, 2022-2031 (USD Million)
  • Table 23 Global Digital Biomanufacturing Market for Vaccines, by Country/ Region, 2022-2031 (USD Million)
  • Table 24 Global Digital Biomanufacturing Market for Cellular-based Biologics Market, by Country/ Region, 2022-2031 (USD Million)
  • Table 25 Global Digital Biomanufacturing Market Gene-based Biologics, by Country/ Region, 2022-2031 (USD Million)
  • Table 26 Global Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 27 Global Digital Biomanufacturing Market for Biopharmaceutical Companies, by Country/ Region, 2022-2031 (USD Million)
  • Table 28 Global Digital Biomanufacturing Market for Academic and Research Institutes, by Country/ Region, 2022-2031 (USD Million)
  • Table 29 Global Digital Biomanufacturing Market for CDMOs &CROs, by Country/ Region, 2022-2031 (USD Million)
  • Table 30 Global Digital Biomanufacturing Market, by Country/ Region, 2022-2031 (USD Million)
  • Table 31 North America: Digital Biomanufacturing Market, by Country, 2022-2031 (USD Million)
  • Table 32 North America: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 33 North America: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million
  • Table 34 North America: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 35 North America: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 36 North America: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 37 North America: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 38 North America: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 39 U.S.: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 40 U.S.: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 41 U.S.: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 42 U.S.: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 43 U.S.: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 44 U.S.: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 45 U.S.: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 46 Canada: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 47 Canada: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 48 Canada: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 49 Canada: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 50 Canada: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 51 Canada: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 52 Canada: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 53 Europe: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Europe: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 55 Europe: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 56 Europe: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 57 Europe: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 58 Europe: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 59 Europe: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 60 Europe: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 61 Germany: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 62 Germany: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 63 Germany: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 64 Germany: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 65 Germany: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 66 Germany: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 67 Germany: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 68 U.K.: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 69 U.K.: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 70 U.K.: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 71 U.K.: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 72 U.K.: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 73 U.K.: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 74 U.K.: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 75 Italy: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 76 Italy: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 77 Italy: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 78 Italy: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 79 Italy: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 80 Italy: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 81 Italy: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 82 Spain: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 83 Spain: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 84 Spain: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 85 Spain: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 86 Spain: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 87 Spain: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 88 Spain: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 89 Switzerland: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 90 Switzerland: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 91 Switzerland: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 92 Switzerland: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 93 Switzerland: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 94 Switzerland: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 95 Switzerland: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 96 Denmark: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 97 Denmark: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 98 Denmark: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 99 Denmark: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 100 Denmark: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 101 Denmark: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 102 Denmark: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 103 Ireland: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 104 Ireland: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 105 Ireland: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 106 Ireland: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 107 Ireland: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 108 Ireland: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 109 Ireland: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 110 Belgium: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 111 Belgium: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 112 Belgium: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 113 Belgium: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 114 Belgium: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 115 Belgium: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 116 Belgium: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 117 Rest of Europe: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 118 Rest of Europe: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 119 Rest of Europe: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 120 Rest of Europe: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 121 Rest of Europe: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 122 Rest of Europe: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 123 Rest of Europe: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 124 Asia-Pacific: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 125 Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 126 Asia-Pacific: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 127 Asia-Pacific: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 128 Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 129 Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 130 Asia-Pacific: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 131 Asia-Pacific: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 132 Japan: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 133 Japan: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 134 Japan: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 135 Japan: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 136 Japan: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 137 Japan: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 138 Japan: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 139 China: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 140 China: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 141 China: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 142 China: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 143 China: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 144 China: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 145 China: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 146 India: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 147 India: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 148 India: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 149 India: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 150 India: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 151 India: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 152 India: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 153 Australia: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 154 Australia: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 155 Australia: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 156 Australia: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 157 Australia: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 158 Australia: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 159 Australia: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 160 South Korea: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 161 South Korea: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 162 South Korea: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 163 South Korea: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 164 South Korea: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 165 South Korea: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 166 South Korea: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 167 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 168 Rest of Asia-Pacific: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 169 Rest of Asia-Pacific: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 170 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 171 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 172 Rest of Asia-Pacific: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 173 Rest of Asia-Pacific: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 174 Latin America: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 175 Latin America: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 176 Latin America: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 177 Latin America: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 178 Latin America: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 179 Latin America: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 180 Latin America: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 181 Latin America: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 182 Brazil: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 183 Brazil: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 184 Brazil: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 185 Brazil: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 186 Brazil: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 187 Brazil: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 188 Brazil: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 189 Mexico: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 190 Mexico: Digital Biomanufacturing software Market, by Type, 2022-2031 (USD Million)
  • Table 191 Mexico: Digital Biomanufacturing software Market, by Deployment, 2022-2031 (USD Million)
  • Table 192 Mexico: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 193 Mexico: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 194 Mexico: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 195 Mexico: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 196 Rest of Latin America: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 197 Rest of Latin America: Digital Biomanufacturing Software Market, by Type, 2022-2031 (USD Million)
  • Table 198 Rest of Latin America: Digital Biomanufacturing Software Market, by Deployment, 2022-2031 (USD Million)
  • Table 199 Rest of Latin America: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 200 Rest of Latin America: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 201 Rest of Latin America: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 202 Rest of Latin America: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 203 Middle East & Africa: Digital Biomanufacturing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 204 Middle East & Africa: Digital Biomanufacturing Market, by Offering, 2022-2031 (USD Million)
  • Table 205 Middle East & Africa: Digital Biomanufacturing Software Market, by Type, 2022-2031 (USD Million)
  • Table 206 Middle East & Africa: Digital Biomanufacturing Software Market, by Deployment, 2022-2031 (USD Million)
  • Table 207 Middle East & Africa: Digital Biomanufacturing Market, by Functionality, 2022-2031 (USD Million)
  • Table 208 Middle East & Africa: Digital Biomanufacturing Market, by Bioprocess, 2022-2031 (USD Million)
  • Table 209 Middle East & Africa: Digital Biomanufacturing Market, by Application, 2022-2031 (USD Million)
  • Table 210 Middle East & Africa: Digital Biomanufacturing Market, by End-user, 2022-2031 (USD Million)
  • Table 211 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 8 Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
  • Figure 9 Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 10 Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 11 Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
  • Figure 12 Global Digital Biomanufacturing Market, by Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global Digital Biomanufacturing Market, by Offering, 2024 VS. 2031 (USD Million)
  • Figure 15 Global Digital Biomanufacturing Market, by Functionality, 2024 VS. 2031 (USD Million)
  • Figure 16 Global Digital Biomanufacturing Market, by Bioprocess, 2024 VS. 2031 (USD Million)
  • Figure 17 Global Digital Biomanufacturing Market, by Application, 2024 VS. 2031 (USD Million)
  • Figure 18 Global Digital Biomanufacturing Market, by End-user, 2024 VS. 2031 (USD Million)
  • Figure 19 Global Digital Biomanufacturing Market, by Geography, 2024 VS. 2031 (USD Million)
  • Figure 20 North America: Digital Biomanufacturing Market Snapshot
  • Figure 21 Europe: Digital Biomanufacturing Market Snapshot
  • Figure 22 Asia-Pacific: Digital Biomanufacturing Market Snapshot
  • Figure 23 Latin America: Digital Biomanufacturing Market Snapshot
  • Figure 24 Key Growth Strategies Adopted by Leading Players, 2022-2024
  • Figure 25 Global Digital Biomanufacturing Market: Competitive Benchmarking, by Offering
  • Figure 26 Global Digital Biomanufacturing Market: Competitive Benchmarking, by Geography
  • Figure 27 Global Digital Biomanufacturing Market: Competitive Dashboard
  • Figure 28 Global Digital Biomanufacturing Market: Market Share Analysis/Market Ranking, By Key Players (2024)
  • Figure 29 GE Healthcare Technologies, Inc.: Financial Snapshot (2024)
  • Figure 30 Siemens AG: Financial Snapshot (2024)
  • Figure 31 Danaher Corporation: Financial Snapshot (2024)
  • Figure 32 ABB Ltd.: Financial Snapshot (2024)
  • Figure 33 Sanofi S.A.: Financial Snapshot (2024)
  • Figure 34 Emerson Electric co.: Financial Snapshot (2024)
  • Figure 35 Honeywell International, Inc.: Financial Snapshot (2024)
  • Figure 36 SAP SE: Financial Snapshot (2024)
  • Figure 37 Schneider Electric SE: Financial Snapshot (2024)
  • Figure 38 Dassault Systemes: Financial Snapshot (2024)
  • Figure 39 Oracle Corporation: Financial Snapshot (2024)
  • Figure 40 3M: Financial Snapshot (2024)
目次
Product Code: MRHC - 1041288

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin] Hardware) Functionality (Product Design, Analytics, Automation) Application (MAB, Protein, Vaccine) Bioprocess-Global Forecast to 2031

The digital biomanufacturing market is projected to reach $50.89 billion by 2031, at a CAGR of 13.3% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the digital biomanufacturing market is driven by growing demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased need for process optimization, increased focus on quality standards & regulatory compliance, strong R&D pipeline for biopharmaceuticals, and rising focus on continuous bioprocessing. However, the high cost of technology deployment and the complex development and manufacturing process of biopharmaceuticals are restraining the growth of this market.

Furthermore, the introduction of industry 4.0 technologies, availability of advanced data analysis tools, and shift towards bioprocessing 4.0 are expected to generate market growth opportunities. However, complexities in process analytical technology (PAT) implementation for downstream processes and intensive capital requirements for biopharmaceutical production are major challenges in the digital biomanufacturing market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (Subsidiary of Siemens) (Germany), Cytiva (a subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric co. (U.S.), Honeywell International Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing. (U.S.), Schneider Electric SE (France), Dassault Systems (France), Oracle Corporation (U.S.), and 3M (U.S.).

Among all the offerings studied in this report, the software segment is expected to account for the largest share of 74.4% of the digital biomanufacturing market. The rising demand for process optimization coupled with the advantages of software in designing, planning, and manufacturing of drugs or biologics support the large share of this segment.

Among all the functionalities studied in this report, in 2024, the process optimization & analytics segment is expected to account for the largest share of the digital biomanufacturing market. Process optimization and analytics help in improving the manufacturing process by streamlining operating procedures. This involves real-time monitoring and analysis of the activities, which helps the organization in finding bugs in the process or deciding the area of improvement. Moreover, this helps in increasing the efficiency of manufacturing equipment and makes the biomanufacturing process efficient.

Among all the bioprocesses studied in this report, in 2024, the downstream bioprocess segment is expected to account for the largest share of the digital biomanufacturing market. Downstream bioprocesses are considered a complex process in nature that requires continuous monitoring. Digital biomanufacturing software helps in improving and maintaining the workflow of these bioprocesses. This also improves the quality of products. Moreover, the use of predictive technology in the software helps reduce the future complexities associated with downstream bioprocesses, which results in reducing extra costs or future loss. Such factors are driving the growth of the market.

Among all the applications studied in this report, in 2024, the monoclonal antibodies segment is expected to account for the largest share of 48.6% of the digital biomanufacturing market. The availability of funding for monoclonal antibody research and development, approvals for monoclonal antibodies, and increasing production capacity of monoclonal antibody manufacturing plants are contributing to the largest share of the segment.

Among all the end users studied in this report, in 2024, the biopharmaceutical companies segment is expected to account for the largest share of the digital biomanufacturing market. Initiatives focused on improving the adoption of biopharmaceuticals, patent expiration of biologics, and increasing awareness of biopharmaceuticals among physicians are supporting the largest share of the market.

An in-depth analysis of the geographical scenario of the digital biomanufacturing printing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Among all the geographies studied in this report, in 2024, North America is expected to account for the largest share of the digital biomanufacturing market. The largest share is attributed to the developed healthcare industry & infrastructure, the presence of major key players, and supportive initiatives focused on improving the adoption of biopharmaceuticals.

Scope of the Report:

Digital Biomanufacturing Market Assessment-by Offering

  • Software
    • by Type
  • Process Analytical Technologies
  • Data Analysis Software
  • Manufacturing Execution Systems
  • Digital Twin
    • by Deployment
  • Cloud-based
  • On-premise
  • Hardware

Digital Biomanufacturing Market Assessment-by Functionality

  • Product Design
  • Process Optimization & Analytics
  • Automation & Control
  • Other Functionalities

Note: Other functionalities include Quality management, predictive maintenance, and data storage.

Digital Biomanufacturing Market Assessment-by Bioprocess

  • Upstream Bioprocess
  • Downstream Bioprocess

Digital Biomanufacturing Market Assessment-by Application

  • Monoclonal Antibodies
  • Recombinant Hormones/Proteins
  • Vaccines
  • Cellular-based Biologics
  • Gene-based Biologics

Digital Biomanufacturing Market Assessment-by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • CDMO &CROs

Digital Biomanufacturing Market Assessment -by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Switzerland
  • Denmark
  • Ireland
  • Belgium
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing and Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. Growing Demand for Biologics
    • 4.2.2. Capacity Expansions of Biopharmaceutical Plants by Key Players
    • 4.2.3. Increased Need for Process Optimization
    • 4.2.4. Increased Focus On Quality Standards & Regulatory Compliance
    • 4.2.5. Strong R&D Pipeline for Biopharmaceuticals
    • 4.2.6. Rising Focus on Continuous Bioprocessing
  • 4.3. Restraints
    • 4.3.1. High Cost of Technology Deployment
    • 4.3.2. Complex Development and Manufacturing Process of Biopharmaceuticals
  • 4.4. Opportunities
    • 4.4.1. Introduction of Industry 4.0
    • 4.4.2. Availability of Advanced Data Analysis Tools
    • 4.4.3. Shift Towards Bioprocessing 4.0
  • 4.5. Challenges
    • 4.5.1. Complexities in Process Analytical Technology (PAT) Implementation for Downstream Processes.
    • 4.5.2. Intensive Capital Requirements for Biopharmaceuticals Production
  • 4.6. Factor Analysis
  • 4.7. Trends
    • 4.7.1. Digital Twin Technology
    • 4.7.2. Integration of Artificial Intelligence (AI) & Machine Learning (ML)
  • 4.8. Regulatory Analysis
  • 4.9. Pricing Analysis
  • 4.10. Porter's Five Force Analysis

5. Digital Biomanufacturing Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. By Type
      • 5.2.1.1. Process Analytical Technology
      • 5.2.1.2. Data Analysis Software
      • 5.2.1.3. Manufacturing Execution System
      • 5.2.1.4. Digital Twin
    • 5.2.2. By Deployment
      • 5.2.2.1. Cloud-based
      • 5.2.2.2. On-Premises
  • 5.3. Hardware

6. Digital Biomanufacturing Market Assessment-by Functionality

  • 6.1. Overview
  • 6.2. Product Design
  • 6.3. Process Optimization & Analytics
  • 6.4. Automation & Control
  • 6.5. Other Functionalities

7. Digital Biomanufacturing Market Assessment-by Bioprocess

  • 7.1. Overview
  • 7.2. Upstream Bioprocessing
  • 7.3. Downstream Bioprocessing

8. Digital Biomanufacturing Market Assessment-by Application

  • 8.1. Overview
  • 8.2. Monoclonal Antibodies
  • 8.3. Recombinant Hormones/Proteins
  • 8.4. Vaccines
  • 8.5. Cellular-based Biologics
  • 8.6. Gene-based Biologics

9. Digital Biomanufacturing Market Assessment-by End-user

  • 9.1. Overview
  • 9.2. Biopharmaceutical Companies
  • 9.3. Academic and Research Institutes
  • 9.4. CDMOs & CROs

10. Digital Biomanufacturing Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Switzerland
    • 10.3.7. Denmark
    • 10.3.8. Ireland
    • 10.3.9. Belgium
    • 10.3.10. Rest of Europe (RoE)
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. South Korea
    • 10.4.5. Australia
    • 10.4.6. Rest of Asia-Pacific (RoAPAC)
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America (RoLATAM)
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis/Market Ranking, by Key Players (2023)

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

  • 12.1. GE Healthcare Technologies, Inc.
  • 12.2. Siemens Xcelerator (subsidiary of Siemens)
  • 12.3. Cytiva (subsidiary of Danaher Corporation)
  • 12.4. ABB Ltd. (Sweden)
  • 12.5. Sanofi S.A.
  • 12.6. Emerson Electric Co.
  • 12.7. Honeywell International, Inc.
  • 12.8. SAP SE
  • 12.9. OVO Biomanufacturing Ltd.
  • 12.10. Schneider Electric SE
  • 12.11. Dassault Systemes
  • 12.12. Oracle Corporation
  • 12.13. 3M

(Note: SWOT analysis of the top 5 companies will be provided.)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports